Results 61 to 70 of about 2,785 (177)

Ulipristal acetate (UPA) for fibroids–IVF outcomes following treatment with UPA after IVF failure: series of 2 case reports [PDF]

, 2017
Uterine fibroids (also known as leiomyomas or myomas) are the most common form of benign uterine tumors. Fibroids are present in 5-10% of infertile patients, and may be the sole cause of infertility in 1-2.4%.
Kale, Ashish R
core   +2 more sources

Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence [PDF]

, 2015
Uterine myoma is the most common benign uterine tumor in women of reproductive age and occurs in 20%–25% of the worldwide population. No currently approved medical treatment is able to completely eliminate fibroids.
Alice Trefoux Bourdet, Dominique Luton, Martin Koskas   +2 more
core   +2 more sources

Sobre la píldora del día después: aspectos a tener en cuenta [PDF]

, 2012
En el número anterior de nuestra revista, apareció un completo e interesante artículo de nuestra compañera Mª Jesús Rodríguez Martínez1 sobre la anticoncepción desde la farmacia comunitaria.
De la Rubia Comos, Juan Miguel
core   +1 more source

A Prospective Observational Cohort Study [PDF]

, 2016
Introduction Uterine leiomyomas are the most common benign gynecologic tumors. To date laparoscopy myomectomy is the gold standard for treatment of symptomatic fibroids in reproductive-aged women.
Baum, Sascha, Hamza, Amr, Joukhadar, Ralf, Juhasz-Boess, Ingolf, Karsten, Maria, Mavrova, Russalina, Radosa, Christoph Georg, Radosa, Julia Caroline, Radosa, Marc Philipp, Solomayer, Erich-Franz, Wagenpfeil, Stefan   +10 more
core   +1 more source

Update on emergency contraception [PDF]

, 2012
pre-printEmergency contraception (EC) is any method used after sexual intercourse to prevent pregnancy. This article provides an overview of the history of EC methods and describes the current availability of oral and intrauterine EC.
Allen RH, CDC, Chalmers R, Cheng L, Farkas M, FDA, FDA, FHI360, Jacobson JC, Kesseru E, Larranaga A, Turok DK, Types of Emergency Contraception, WHO, Yuzpe AA, Zinaman MJ   +15 more
core   +1 more source

Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate. [PDF]

Hum Mol Genet, 2023
Kolterud Å, Välimäki N, Kuisma H, Patomo J, Ilves ST, Mäkinen N, Kaukomaa J, Palin K, Kaasinen E, Karhu A, Pasanen A, Bützow R, Heikinheimo O, Kopp Kallner H, Aaltonen LA.   +14 more
europepmc   +1 more source

The use of a short course of Ulipristal Acetate for acute abnormal uterine bleeding in women without uterine fibroids. [PDF]

Facts Views Vis Obgyn, 2023
Lambrecht I, Van den Bosch T.
europepmc   +1 more source

Decreased growth differentiation factor 9, bone morphogenetic protein 15, and forkhead box O3a expressions in the ovary via ulipristal acetate. [PDF]

Rev Assoc Med Bras (1992), 2023
Fındık DG, Kaplanoğlu GT, Arık GN, Alemari NBA.   +3 more
europepmc   +1 more source

DEVELOPMENT AND VALIDATION OF UV SPECTROMETRIC METHOD FOR QUANTITATIVE DETERMINATION OF ULIPRISTAL ACETATE [PDF]

, 2015
Objective: To develop and validate UV spectrometric method for quantitative determination of ulipristal acetate.Methods: The solvent selected was methanol and detection was carried out at 302 nm.Results: Linearity of the proposed method was found to be ...
Bari, Apexa K, Desai, Sonal S, Modi, Vishal S, Prajapati, Parixit R   +3 more
core  

The progesterone-receptor modulator, ulipristal acetate, drastically lowers breast cell proliferation. [PDF]

Breast Cancer Res Treat, 2022
Westhoff CL, Guo H, Wang Z, Hibshoosh H, Polaneczky M, Pike MC, Ha R.   +6 more
europepmc   +1 more source